Pasco Reporter

Representatives Gus Bilirakis, Paul Tonko, Dan Crenshaw, Ro Khanna, Scott Peters, and Sam Liccardo have announced the re-launch of the Congressional Caucus for Longevity Science. This initiative is designed to inform congressional members about the advancements in aging and longevity biotechnology and encourage efforts aimed at increasing the healthy lifespan of Americans.

With an increasing aging population, the initiative emphasizes the potential to reduce economic and healthcare burdens through investment in research focused on delaying aging and preventing chronic diseases. The caucus highlights the importance of supporting longevity science as a strategy that benefits individuals and the broader economy.

Representative Gus Bilirakis, a senior member of the House Energy and Commerce Committee, is a co-chair of the caucus alongside Representative Paul Tonko. Bilirakis remarked, "Increasing life expectancy and promoting positive health outcomes are important priorities, and the formation of this caucus is an important step toward achieving those goals. I believe in promoting individual responsibility and supporting innovation in the pursuit of scientific discoveries that will enable Americans to live happier and longer lives. I am honored to co-chair this bipartisan effort with my colleague, Congressman Tonko. We will work with our colleagues in an effort to make a significant impact on the future health and wellness for our constituents."

Paul Tonko, also a member of the House Energy and Commerce Committee, stated, "With life expectancy in the United States at its lowest in decades, we in Congress need to come together to address this decline and support science and research that will enable people to live fuller and healthier lives. We’re doing just that with the Longevity Caucus. I am grateful for the partnership of Congressman Bilirakis in leading this Caucus and look forward to working in strong bipartisan fashion to help improve our quality and longevity of life, particularly in the fight against neurodegenerative diseases with aging as the greatest risk factor."